Clinical Trial Update: Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating post-transplant azacitidine to prevent relapse in acute myeloid leukemia and myelodysplastic syndrome; trial completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, AML | Phase 3 | Status: COMPLETED | Results posted: 2020-01-14